Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myeloablative”

385 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 385 results

Not applicableUnknownNCT00295997
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia

Who this might be right for
Chronic Myeloproliferative DisordersKidney CancerLeukemia+4 more
University of California, San Francisco 35
Early research (Phase 1)Temporarily pausedNCT00664196
What this trial is testing

Trial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative Conditioning

Who this might be right for
Prostate Cancer
Roger Williams Medical Center 18
Large-scale testing (Phase 3)UnknownNCT00209222
What this trial is testing

Efficacy of R-CHOP vs R-CHOP/R-DHAP in Untreated MCL

Who this might be right for
Lymphoma, Mantle-Cell
European Mantle Cell Lymphoma Network 360
Testing effectiveness (Phase 2)Study completedNCT00578942
What this trial is testing

Allo Non-myeloablative SCT Utilizing Matched Family Member Stem Cells Purged Using Campath

Who this might be right for
LymphomaMyelomaLeukemia+2 more
David Rizzieri, MD 48
Not applicableUnknownNCT05905770
What this trial is testing

Do Alemtuzumab Levels Predict T Cell Chimerism After MSD SCT for SCD?

Who this might be right for
Sickle Cell Disease
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 20
Testing effectiveness (Phase 2)Looking for participantsNCT04491370
What this trial is testing

Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma

Who this might be right for
B-cell LymphomaBurkitt LymphomaDiffuse Large B Cell Lymphoma+6 more
New York Medical College 20
Not applicableStudy completedNCT00525876
What this trial is testing

Non-Myeloablative Allogeneic Stem Cell Transplantation

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 49
Testing effectiveness (Phase 2)Study completedNCT02414945
What this trial is testing

TILs & Low-Dose IL-2 Therapy Following Cyclophosphamide and Fludarabine in Pleural Mesothelioma Patients

Who this might be right for
Pleural Mesothelioma
University Health Network, Toronto 9
Testing effectiveness (Phase 2)WithdrawnNCT00003273
What this trial is testing

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor

Who this might be right for
Brain and Central Nervous System TumorsNeuroblastomaRetinoblastoma+1 more
NYU Langone Health
Large-scale testing (Phase 3)Study completedNCT00130754
What this trial is testing

Thymoglobuline in Non-myeloablative Allogeneic Stem-cell Transplantation

Who this might be right for
Stem Cell TransplantationGraft Vs Host Disease
Hadassah Medical Organization 30
Not applicableStudy completedNCT01520623
What this trial is testing

Complement and Graft-versus-host Disease

Who this might be right for
Allografted With Myeloablative Conditioning
Assistance Publique - Hôpitaux de Paris 70
Large-scale testing (Phase 3)Ended earlyNCT00714259
What this trial is testing

Non-Myeloablative Allogeneic HSCT From HLA Matched Related or Unrelated Donors for the Treatment of Low Grade B Cell Malignancies

Who this might be right for
Multiple MyelomaCLL / SLLNon Hodgkin's Lymphoma+2 more
University of Alabama at Birmingham 5
Testing effectiveness (Phase 2)Study completedNCT00849147
What this trial is testing

Bone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603)

Who this might be right for
Precursor B-Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteBurkitt Lymphoma+3 more
Medical College of Wisconsin 55
Testing effectiveness (Phase 2)Study completedNCT00350181
What this trial is testing

Sirolimus & Mycophenolate Mofetil as GVHD Prophylaxis in Myeloablative, Matched Related Donor HCT

Who this might be right for
LeukemiaLymphoma, Non-HodgkinHematologic Diseases+1 more
Stanford University 11
Large-scale testing (Phase 3)UnknownNCT00392886
What this trial is testing

Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Children's Hospital Los Angeles 120
Testing effectiveness (Phase 2)Study completedNCT00262886
What this trial is testing

Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
University of Rochester 35
Testing effectiveness (Phase 2)Ended earlyNCT01375023
What this trial is testing

Allogenic Haematopoietic Cell Transplantation for Patients With Refractory "Triple Negative" Breast Cancer

Who this might be right for
Breast Cancer
European Institute of Oncology 3
Testing effectiveness (Phase 2)Study completedNCT00580034
What this trial is testing

Allo Non-Myeloablative SCT Utilizing Mis-Matched Family Member Stem Cells Purged Using Campath

Who this might be right for
LymphomaMyelomaLeukemia+2 more
David Rizzieri, MD 176
Early research (Phase 1)Study completedNCT00374933
What this trial is testing

Enhancing Graft vs Leukemia Via Delayed Ex-Vivo Co-Stimulated DLI After Non-Myeloablative Stem Cell Transplantation

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome
Abramson Cancer Center at Penn Medicine 18
Large-scale testing (Phase 3)Study completedNCT00469729
What this trial is testing

Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy

Who this might be right for
Hematologic MalignanciesAcute Myeloid LeukemiaLymphoid Leukemia+4 more
Gamida Cell -Teva Joint Venture Ltd. 101
Load More Results